Search PubMed⌕ Search

Biomedical subjects

P Wilde

Publications and source records attributed to P Wilde.

At least 19 recordsLinked to original sources
PubMed1998

Prognosis following prenatal diagnosis of heart malformations.

Our objective was to document the prognosis of cases with fetal heart malformations (FHM). Forty-two fetuses assessed both in a regional fetal medicine and paediatric cardiology unit were classified prenatally into isolated FHM or those associated with extra-cardiac structural or karyotypic anomalies (ECA) and this classification was not changed subsequently (analogous to an intention to treat analysis). The end points studied included chromosomal abnormality, pregnancy outcome and follow-up at one year of age. FHM were isolated in 16 (38%) and associated with ECA in 26 (62%) of cases. The karyotypic abnormality rate was 8/42 (19%) overall and 8/26 (31%) in ECA cases. The pregnancy outcome included termination of pregnancy in 19 (45%), intrauterine death of two (5%) and live birth in 21 (50%). 12/16 (75%) of isolated FHM cases were live born compared with 9/26 (35%) of ECA cases (P < 0.03). Of the isolated FHM live born babies, 8/12 (67%) were alive at the end of the first year and seven of these were growing normally and did not require cardiac medication. However, a considerable proportion of their first year was spent in hospital (median 8%, interquartile range 5-10). Only one of nine ECA live born cases was alive but with poor growth and dependence on cardiac drugs at one year. These data confirm previous findings in prenatal diagnosis series that the prognosis for FHM is worse than that reported in studies of congenital heart disease at birth and is strongly dependent upon the presence of ECA. In their absence, outcome is better than previously published. Counselling must take place only after full fetal medicine assessment and should be based upon prenatal data.

Female↗
PubMed1998

Hemodynamic performance of the 21-mm St. Jude BioImplant prosthesis using dobutamine Doppler echocardiography.

This study examines the hemodynamic performance of small size St. Jude BioImplant aortic prostheses using dobutamine echocardiography. Eleven patients (3 women, mean age 75 years) who had undergone aortic valve replacement with a size 21-mm St. Jude BioImplant aortic prostheses at 10.8 +/- 5.1 months (SD) previously were studied. Dobutamine infusion was started at a rate of 5 microg/kg/min and increased to 10 microg/kg/min, and subsequently to 20 microg/kg/min at 15-minute intervals. Pulsed and continuous-wave Doppler studies were performed at rest and at the end of each stage. Effective orifice area, mean gradient, and the performance index across each prosthesis were calculated and cardiac output was determined by Doppler measurement of flow in the left ventricular outflow tract. Stress dobutamine increased heart rate and cardiac output by 51% and 56%, respectively (both p <0.0001), and the mean transvalvular gradient increased from 30.1 +/- 7.5 mm Hg at rest to 49.3 +/- 11.5 mm Hg at maximum stress (p <0.0005). The performance index increased progressively from 0.29 +/- 0.05 at rest to 0.40 +/- 0.10 at maximum stress (p <0.0005). Regression modeling analyses demonstrated that the maximum stress gradient was independent of all variables except the resting gradient (p = 0.03). Body surface area had no effect on the changes in cardiac output, effective orifice area, or transprosthetic gradient at maximum stress. Thus, these data demonstrate that the size 21-mm St. Jude BioImplant prosthesis exhibits suboptimal hemodynamic performance with transvalvular gradients consistent with mild to moderate aortic stenosis, both at rest and under stress conditions.

Adrenergic beta-Agonists↗
PubMed1998

Treatment of type-two odontoid fractures in halothoracic vests.

We treated 22 patients with type-two odontoid fractures in halothoracic vests for six to eight weeks followed by a Philadelphia collar for four weeks. Eighteen patients were reviewed by questionnaire and radiography at a mean of 40 months after injury. We assessed union, fracture position, the degree of permanent pain and stiffness, satisfaction with the treatment and the outcome. The overall union rate was 82%. Posterior malunion with residual posterior displacement or angulation was associated with a higher incidence of persisting pain. The position at union did not correlate with the residual cervical stiffness. Fractures failed to unite in four patients (18%) none of whom had late neurological sequelae, although they had more late pain. There were associations between the development of nonunion and an extension-type injury, age over 65 years and delay in diagnosis.

Adolescent↗
PubMed1997

Left ventricular volume reduction surgery.

Left ventricular volume reduction has recently been introduced as a surgical treatment for end stage dilated cardiomyopathy. This operation involves the resection of a slice of viable left ventricular myocardium in order to reduce the wall tension imposed upon the contracting heart chamber. Early results are encouraging, but clinical evaluation on a larger scale is required. In the present article, we describe the indications, surgical principles and results of left ventricular volume reduction surgery with reference to our group's experience.

Animals↗
PubMed1997

Staged minimally invasive direct coronary artery bypass and percutaneous angioplasty for multivessel coronary artery disease.

OBJECTIVE: Minimally invasive direct coronary artery bypass (MIDCAB) using the left internal mammary artery (IMA) to the left anterior descending (LAD) coronary artery can be performed with low operative risk. MIDCAB can be combined with percutaneous transluminal coronary angioplasty (PTCA) to treat patients with multivessel disease. We report here our experience with staged MIDCAB and PTCA in the management of a selected group of patients. METHODS AND RESULTS: 11 patients (9 males, mean age 64.6+/-8.7 years) with multivessel coronary artery disease received left IMA grafts to the LAD using the MIDCAB approach. There were no postoperative morbidity or mortality. All patients were extubated within 4 h of leaving the operating room with a mean ITU stay of 12.8 h. All patients but two underwent coronary angioplasty during the same hospital admission, 3.8+/-1.3 days after the MIDCAB procedure. Angiography confirmed IMA grafts patency in all patients, and complete revascularisation by PTCA of other coronary arteries was possible in all patients but one. Mean hospital stay was 5.9 days, and all patients remain free of angina at a mean follow-up period of 11.4 months. CONCLUSIONS: Staged MIDCAB and angioplasty is an experimental approach for the management of selected patients with multi-vessel coronary artery disease. Further experience is needed to clarify patient selection and the long-term outcome of this approach.

Aged↗
PubMed1997

Dynamic evaluation of the 21-mm Medtronic Intact aortic bioprosthesis by dobutamine echocardiography.

BACKGROUND: High residual transvalvular gradients have been reported with the use of small Medtronic Intact aortic valve prostheses. The aim of this study was to evaluate the hemodynamic performance of 21-mm prostheses using dobutamine Doppler echocardiography. METHODS: Ten patients (7 women; mean age, 79 years) who had undergone aortic valve replacement with 21-mm Medtronic Intact prostheses 19.1 +/- 9.9 (standard deviation) months previously were studied. Dobutamine infusion was started at a rate of 5 microg x kg(-1) x min(-1) and increased to 10 and 20 microg x kg(-1) x min(-1) at 15-minute intervals. Pulsed and continuous-wave Doppler studies were performed at rest and at the end of each stage. Effective orifice area, performance index, and discharge coefficient of each valve were calculated, and peak and mean velocity and pressure drop across the prostheses were measured. Cardiac output was determined by Doppler measurement of flow in the left ventricular outflow tract. RESULTS: Dobutamine stress increased heart rate and cardiac output by 68% and 65%, respectively (both p < 0.005), and mean transvalvular gradient increased from 19.1 +/- 5.1 mm Hg at rest to 33.2 +/- 7.7 mm Hg at maximum stress (p < 0.0001). Regression analyses demonstrated that maximum-stress gradient was independent of all variables except resting gradients (p < 0.004). Body surface area had no effect on the changes in cardiac output, effective orifice area, or transprosthetic gradient at maximum stress. CONCLUSIONS: These data show that the 21-mm Medtronic Intact aortic prosthesis exhibits acceptable hemodynamic performance. Transvalvular gradients remained within a clinically acceptable range, both at rest and at maximum stress. Moreover, overall hemodynamic performance suggests that patient-prosthesis mismatch is unlikely to be a problem of clinical importance when this prosthesis is used.

Aged↗
PubMed1997

Hemodynamics of St. Jude Medical prostheses in the small aortic root: in vivo studies using dobutamine Doppler echocardiography.

BACKGROUND AND AIMS OF THE STUDY: The well known correlation between prosthetic valve orifice area and transvalvular pressure drop has raised concerns about the presence of significant residual gradients when only a small-sized prosthesis can be implanted, particularly in patients with a large body surface area. The aim of this study was to study the hemodynamic performance of small-size St. Jude Medical aortic prostheses using dobutamine echocardiography. METHODS: Fifteen patients (14 females, one male, of mean age 67 years) who had undergone aortic valve replacement with size 19 mm St. Jude Medical prostheses at a mean of 19 +/- 8 (SD) months previously were studied. Dobutamine infusion was started at a rate of 5 micrograms/kg/min and increased to 10 and subsequently to 20 micrograms/kg/min at 15-min intervals. Pulsed and continuous-wave Doppler studies were performed at rest and at the end of each stage. Effective orifice area (EOA) and mean gradient across each prosthesis were calculated, and cardiac output (CO) was determined by Doppler measurement of flow in the left ventricular outflow tract. RESULTS: Dobutamine-stress increased heart rate and cardiac output by 57% and 86% respectively (both p < 0.0005), and mean transvalvular gradient increased from 22.0 +/- 4.9 mmHg at rest to 41.9 +/- 9 mmHg at maximum stress (p < 0.0001). Regression modeling analyses demonstrated that maximum stress gradient was independent of all variables except resting gradient (p = 0.0068). Body surface areas had no effect on the changes in cardiac output, effective orifice area or transprosthetic gradient at maximum stress. CONCLUSIONS: These data demonstrate that the size 19 mm St. Jude Medical prosthesis exhibits favorable hemodynamic performance. Transvalvular gradients remained within a clinically acceptable range, both at rest and under stress conditions. Moreover, in the patient population studied, overall hemodynamic performance indicates that with St. Jude Medical aortic valves, patient-prosthesis mismatch is unlikely to be a problem of clinical importance.

Adult↗
PubMed1996

Comparison of hemodynamic performances of St. Jude Medical and CarboMedics 21 mm aortic prostheses by means of dobutamine stress echocardiography.

Dobutamine stress Doppler echocardiography was used to compare the hemodynamic performance of two small aortic bileaflet prostheses. Nineteen patients (14 female, mean age 64 years) who had undergone aortic valve replacement with 21 mm bileaflet valve prostheses (St. Jude Medical valve, n = 9, or CarboMedics valve, n = 10) were studied. Dobutamine infusion was started at a rate of 5 micrograms.kg-1.min-1 and increased to 10 and 20 micrograms.kg-1.min-1 at 15-minute intervals. Under maximum stress, heart rate and cardiac output increased by 70% and 120%, respectively, and mean arterial blood pressure decreased by 9%. Pulsed-wave and continuous-wave Doppler studies were performed at rest and at the end of each stage. Velocity ratio, effective orifice area, performance index, and discharge coefficient of the valve were calculated, and peak and mean velocities and pressure drops across the prostheses were measured. Dobutamine infusion produced similar increases in cardiac output in all patients. Effective orifice areas, discharge coefficients, and performance indexes were comparable for the two valve groups both at rest and maximum stress. Transvalvular velocities and pressure drops were also similar in the two valve groups. Transvalvular pressure drops were also comparable in patients with large body surface area. Dobutamine stress echocardiography is useful in the evaluation of the hemodynamic performance of prosthetic heart valves. St. Jude Medical and CarboMedics 21 mm prostheses have equally favorable hemodynamic performances in most patients under conditions of high cardiac output.

Aged↗
PubMed1995

Evaluation of the hemodynamic performance of small CarboMedics aortic prostheses using dobutamine-stress Doppler echocardiography.

BACKGROUND: The well-known correlation between prosthetic valve orifice area and transvalvular gradients has raised concerns about the presence of significant residual gradients when the size of the prosthesis that can be implanted is limited by the presence of a small aortic annulus. METHODS: Dobutamine-stress Doppler echocardiography was used to evaluate the hemodynamic performance of small CarboMedics aortic prostheses (19 mm and 21 mm) in 18 patients (16 women; mean age, 64 years) who had undergone aortic valve replacement 23.5 +/- 19 months (standard deviation) previously. Dobutamine infusion was started at a rate of 5 micrograms.kg-1.min-2 and increased to 10 and 20 micrograms.kg-1.min-2 at 15-minute intervals. Pulsed and continuous wave Doppler studies were performed at rest and at the end of each stage. Effective orifice area, performance index, and discharge coefficient of both valves were calculated, and peak and mean velocity and pressure drop across the prostheses were measured. RESULTS: Heart rate and cardiac output increased by 74% and 94%, respectively, and mean arterial blood pressure decreased by 9% at maximum stress. Effective orifice area, discharge coefficient, and performance index were comparable in both valve sizes at rest and maximum stress. Also, there was no significant difference in mean transvalvular pressure drop (gradient) for 19-mm and 21-mm prostheses at rest (8.1 +/- 8.4 and 4.8 +/- 3.8 mm Hg) or maximum stress (15.1 +/- 14.2 and 8.8 +/- 5.8 mm Hg, respectively). No significant correlation could be demonstrated between transvalvular pressure drop and patient's body surface area. CONCLUSIONS: These data show that 19-mm and 21-mm CarboMedics aortic prostheses exhibit equally favorable hemodynamic performance with minimal pressure gradient, both at rest and under stress conditions.

Aged↗
PubMed1994

Transesophageal echocardiographic measurements of cardiac output in cardiac surgical patients.

Transesophageal echocardiography is becoming increasingly popular as a method of intraoperative monitoring because it can be performed continuously, does not transgress the sterile operative field, and provides data with regard to valve function, ventricular volumes, and contractility. Recently it was suggested that it can be used to measure cardiac output; however, controversy remains regarding its accuracy. Cardiac output was measured simultaneously by transesophageal echocardiography (using a 5-MHz pulse-wave Doppler, single-plane viewing probe) and by the thermodilution method in 21 patients undergoing open heart operations. The cardiac outputs measured by thermodilution correlated poorly (r = 0.45) with the transesophageal values derived from the left ventricular cross-sectional area, and the mean difference was 0.47 +/- 2.17 (standard deviation) L.min-1, giving limits of agreement of from -3.87 to +4.81 L.min-1. Cardiac outputs measured by thermodilution correlated well (r = 0.95) with transesophageal Doppler values derived from pulmonary artery flow velocity, with a mean difference of 0.12 +/- 0.45 L.min-1 and narrow limits of agreement of from -0.78 to +1.02 L.min-1. Based on our findings, transesophageal Doppler echocardiographic determination of cardiac output using pulmonary artery flow measurements can provide accurate hemodynamic data in patients undergoing cardiac operations.

Aged↗
PubMed1994

Case report: spontaneous coronary artery dissection.

Spontaneous coronary artery dissection is a rare cause of ischaemic heart disease occurring most commonly in young women. It is frequently fatal. Our case is unusual in that a very long dissection flap was diagnosed by coronary angiography in a male patient who presented with only minor symptoms. We discuss the pathogenesis of spontaneous dissection and the prognosis for this group of patients.

Adult↗
PubMed1994

Early experience with the Jyros bileaflet valve. Is leaflet rotation clinically important?

The design of the Jyros bileaflet prosthesis provides for a continuous, circumferential rotation of the hinge. Previous in vitro testing has confirmed the uninterrupted gyration of the leaflets, which reduces the risk of stasis within the hinge area, and as a consequence, possibly reduces the risk of thromboembolism. Twenty Jyros bileaflet valves were implanted in 19 patients between July 1991 and September 1992. There was one hospital death not related to the prosthesis. One valve had to be removed from the mitral position immediately after implantation because preservation of the posterior mitral leaflet led to malfunction of the prosthesis. Clinical and radiological follow up demonstrated that all surviving patients were clinically well, but nine of the remaining 18 valves (50%) showed no rotation of the leaflets.

Adult↗
PubMed1994

Hemodynamic effects and echocardiographic consequences of tension-free pericardial closure after heart valve surgery.

Pericardial closure early after open heart surgery has been shown to consistently lower cardiac output and stroke volume, while mean arterial blood pressure is maintained by an increase in systemic vascular resistance. In 10 patients (seven females) (mean age 65 +/- 4 years) undergoing an open heart valve procedure, the effects of a tension-free pericardial closure technique were studied using thermodilution studies and transesophageal echocardiography. The following variables were recorded: mean arterial pressure, mean pulmonary artery pressure, right atrial pressure, cardiac output, stroke volume, systemic vascular resistance, and systolic and diastolic left ventricular dimensions, and left ventricular wall thickness. Observations were made after the heart was decannulated, both while the pericardium was open and after it had been closed by a tension-free technique, and then after closure of the chest. Further observations were made while the chest remained closed, both before and after the pericardium had been reopened by removing the pericardial suture through the chest wall. Closing the pericardium with the tension-free technique while the chest remained open was followed by a fall in cardiac output by 8% and a 15% fall in systemic vascular resistance (both n.s.). These changes caused a 13% reduction in the mean arterial pressure (p = 0.03). Ejection fraction did not change, and systolic and diastolic left ventricular dimensions decreased by 6% and 4% respectively (both n.s.). Opening the pericardium (1.5 to 2 hours after the end of the operation) while the chest remained closed was not followed by significant change in any of the hemodynamic or echocardiographic variables.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗